Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
154.30    1.80 (1.18%)
Bid:
153.90
Ask:
154.30
Spread: 0.40 (0.26%)
Market Cap: £1.60b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

Form 8.3 - Currys PLC

28 Feb 2024 13:15

RNS Number : 8252E
SIH Partners LLLP
28 February 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

SIH Partners, LLLP (SIHP)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Susquehanna International Securities Limited (SISLTD)

Note - SISLTD is a subsidiary of SIHP.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Currys plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

27 February 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1p Ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

22,468,345

1.98%

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

49,969,000

4.40%

35,686,000

3.14%

 

TOTAL:

49,969,000

4.40%

58,154,345

5.12%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

(GBP)

0.1p Ordinary

Sale

(76,532)

0.665

0.1p Ordinary

Sale

(500,000)

0.6738

0.1p Ordinary

Sale

(500,000)

0.6743

0.1p Ordinary

Sale

(53,094)

0.7205

0.1p Ordinary

Sale

(14,688)

0.7215

0.1p Ordinary

Sale

(43,396)

0.722

0.1p Ordinary

Purchase

38,266

0.665

0.1p Ordinary

Purchase

35,396

0.7205

0.1p Ordinary

Purchase

7,344

0.7215

0.1p Ordinary

Purchase

27,293

0.722

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Equity Option

CALL

Purchase

10000

72

American

Mar-24

0.03

Equity Option

CALL

Purchase

20000

72

American

Mar-24

0.0275

Equity Option

CALL

Purchase

20000

68

American

Mar-24

0.05

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

Yes

 

 

Date of disclosure:

28 February 2024

Contact name:

Olive Fogarty

Telephone number*:

+353-1-802-8059

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

Full name of person making disclosure:

SIH Partners, LLLP

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Currys plc

 

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

(GBP)

Type

e.g. American, European etc.

Expiry date

0.1p Ordinary

PUT Option

Purchased

(26,500,000)

40

American

Mar-25

0.1p Ordinary

PUT Option

Purchased

(9,100,000)

40

American

Sep-24

0.1p Ordinary

PUT Option

Purchased

(20,000)

70

American

Apr-24

0.1p Ordinary

CALL Option

Sold

(20,000)

64

American

Apr-24

0.1p Ordinary

PUT Option

Purchased

(10,000)

70

American

Jun-24

0.1p Ordinary

CALL Option

Sold

(10,000)

64

American

Jun-24

0.1p Ordinary

CALL Option

Sold

(10,000)

60

American

Mar-24

0.1p Ordinary

PUT Option

Purchased

(10,000)

64

American

Jun-24

0.1p Ordinary

CALL Option

Sold

(4,000)

56

American

Mar-24

0.1p Ordinary

PUT Option

Purchased

(2,000)

60

American

Mar-24

0.1p Ordinary

CALL Option

Purchased

1,000

68

American

Mar-24

0.1p Ordinary

CALL Option

Purchased

10,000

70

American

Jun-24

0.1p Ordinary

CALL Option

Purchased

11,000

72

American

Apr-24

0.1p Ordinary

CALL Option

Purchased

15,000

68

American

Dec-24

0.1p Ordinary

CALL Option

Purchased

30,000

72

American

Mar-24

0.1p Ordinary

PUT Option

Sold

210,000

60

American

Apr-24

0.1p Ordinary

PUT Option

Sold

1,328,000

48

American

Mar-24

0.1p Ordinary

PUT Option

Sold

6,500,000

50

American

Jun-24

0.1p Ordinary

CALL Option

Purchased

41,864,000

50

American

Sep-24

3. AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

These options options have been purchased by Susquehanna International Securities limited (SISLTD), a subsidiary of SIH Partners, LLLP (SIHP) as part of a market making strategy. There are no agreements to purchase or sell in place.

 

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETPPUWGPUPCGWR
Date   Source Headline
18th Jan 20247:00 amRNSStrengthening performance in a tough environment
2nd Jan 202412:52 pmRNSTotal Voting Rights
21st Dec 20232:54 pmRNSHolding(s) in Company
21st Dec 202310:40 amRNSHolding(s) in Company
20th Dec 20239:54 amRNSHolding(s) in Company
14th Dec 20235:24 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSSolid performance in a tough environment
1st Dec 20239:06 amRNSTotal Voting Rights
21st Nov 202312:01 pmRNSResult of Meeting
3rd Nov 202312:25 pmRNSShareholder Circular and Notice of General Meeting
3rd Nov 20237:05 amRNSProposed Disposal of Kotsovolos
1st Nov 20239:41 amRNSTotal Voting Rights
10th Oct 20237:27 amRNSUpdate on Strategic Review of Kotsovolos
6th Oct 20233:16 pmRNSHolding(s) in Company
2nd Oct 202311:26 amRNSTotal Voting Rights
28th Sep 202310:55 amRNSHolding(s) in Company
20th Sep 202310:35 amRNSDirector/PDMR Shareholding
19th Sep 202310:35 amRNSHolding(s) in Company
7th Sep 20231:51 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM Trading Statement
1st Sep 20239:09 amRNSTotal Voting Rights
22nd Aug 20233:58 pmRNSDirector/PDMR Shareholding
17th Aug 202312:40 pmRNSDirector/PDMR Shareholding
4th Aug 20239:44 amRNSDirector/PDMR Shareholding
3rd Aug 202312:54 pmRNSAnnual Financial Report
3rd Aug 20239:25 amRNSDirector/PDMR Shareholding
1st Aug 202311:09 amRNSTotal Voting Rights
28th Jul 202310:58 amRNSDirector/PDMR Shareholding
13th Jul 20238:30 amRNSHolding(s) in Company
12th Jul 20234:14 pmRNSHolding(s) in Company
11th Jul 20239:42 amRNSHolding(s) in Company
10th Jul 20232:59 pmRNSDirector/PDMR Shareholding
7th Jul 202310:36 amRNSDirector/PDMR Shareholding
6th Jul 20231:26 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSStrengthening UK&I offset by poor Nordics
3rd Jul 20239:55 amRNSTotal Voting Rights
26th Jun 202312:14 pmRNSHolding(s) in Company
23rd Jun 20234:23 pmRNSHolding(s) in Company
22nd Jun 20239:22 amRNSHolding(s) in Company
19th Jun 20235:20 pmRNSHolding(s) in Company
19th Jun 20234:38 pmRNSHolding(s) in Company
16th Jun 20237:00 amRNSStrategic Review of Kotsovolos
2nd Jun 202310:37 amRNSDirectorate Change
1st Jun 20239:33 amRNSTotal Voting Rights
24th May 20238:37 amRNSResponse to ESA announcement
15th May 20237:00 amRNSTrading Statement
3rd May 20235:21 pmRNSHolding(s) in Company
2nd May 202311:43 amRNSTotal Voting Rights
11th Apr 20235:53 pmRNSHolding(s) in Company
5th Apr 202310:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.